• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有晚期子宫颈癌的104岁女性。

A 104-year-old woman with advanced cervical carcinoma of the uterus.

作者信息

Sakurai Hideyuki, Niibe Hideo, Suzuki Mitsuo, Nakano Takashi

机构信息

Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.

出版信息

Gynecol Oncol. 2004 Feb;92(2):713-5. doi: 10.1016/j.ygyno.2003.10.035.

DOI:10.1016/j.ygyno.2003.10.035
PMID:14766273
Abstract

BACKGROUND

Treatment of elderly patient with advanced cancer includes considerable problems because of their limited life expectancy.

CASE

A 104-year-old woman with FIGO stage IIIB uterine cervical carcinoma treated with external beam radiotherapy and high dose-rate brachytherapy. After the treatment, the serum squamous cell carcinoma (SCC) antigen had fallen to normal level. She is now living 66 months after the treatment without recurrent symptoms.

CONCLUSION

In this specific case, the significance of this treatment is that the patient is surviving at the age of 109.

摘要

背景

由于预期寿命有限,老年晚期癌症患者的治疗存在诸多问题。

病例

一名104岁女性,国际妇产科联盟(FIGO)分期为IIIB期的子宫颈癌,接受了体外照射放疗和高剂量率近距离放疗。治疗后,血清鳞状细胞癌(SCC)抗原降至正常水平。她现在在治疗后已存活66个月,无复发症状。

结论

在这个特殊病例中,这种治疗的意义在于患者在109岁时仍存活。

相似文献

1
A 104-year-old woman with advanced cervical carcinoma of the uterus.一名患有晚期子宫颈癌的104岁女性。
Gynecol Oncol. 2004 Feb;92(2):713-5. doi: 10.1016/j.ygyno.2003.10.035.
2
The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer.鳞状细胞癌(SCC)抗原在宫颈癌患者放疗后随访中的影响。
Anticancer Res. 2000 Nov-Dec;20(6D):5113-5.
3
Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.测量血清鳞状细胞癌抗原水平作为子宫颈癌患者放射反应的预测指标。
Cancer. 2003 Jun 15;97(12):3114-20. doi: 10.1002/cncr.11453.
4
Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.单纯放疗治疗晚期宫颈鳞状细胞癌患者的风险分层
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):492-9. doi: 10.1016/j.ijrobp.2005.02.012.
5
Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.宫颈癌低氧与常氧外照射联合锎-252中子近距离治疗。一项5年随机研究的对比治疗结果。
Strahlenther Onkol. 2005 May;181(5):273-84. doi: 10.1007/s00066-005-1303-0.
6
[Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].[鳞状细胞癌抗原对复发性子宫颈鳞状细胞癌患者的影响]
Zhonghua Fu Chan Ke Za Zhi. 2008 Jan;43(1):13-7.
7
Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.术前血清鳞状细胞癌抗原水平在早期宫颈癌患者临床决策中的应用
J Clin Oncol. 2005 Mar 1;23(7):1455-62. doi: 10.1200/JCO.2005.02.123.
8
Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.
Anticancer Res. 1997 Jul-Aug;17(4B):2959-62.
9
High-dose-rate brachytherapy in uterine cervical carcinoma.子宫颈癌的高剂量率近距离放射治疗
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):125-30. doi: 10.1016/j.ijrobp.2004.09.017.
10
Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.鳞状细胞癌抗原在宫颈癌放疗随访中的应用:成本效益评估
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1145-9. doi: 10.1016/j.ijrobp.2007.04.055. Epub 2007 Aug 6.